MEDICAMEQ

MEDICAMEN BIOTECH

Small Cap BSE: 531146 NSE: MEDICAMEQ
₹983.4
-5.7 (-0.58%)
As on 30 September, 2022 | 02:56

Medicamen Biotech Share Price

Medicamen Biotech Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in MEDICAMEN BIOTECH

Start SIP

Medicamen Biotech Share Returns

  • Over 1 Month -13.21%
  • Over 3 Month 38.94%
  • Over 6 Month 56.44%
  • Over 1 Year

Medicamen Biotech Key Statistics

P/E Ratio 83.8
PEG Ratio 39.9
Market Cap Cr 1,244
Price to Book Ratio 8.2
EPS 12.2
Dividend 0.1
Relative Strength Index 44.05
Money Flow Index 44.52
MACD Signal 41.38
Average True Range 63.17

Medicamen Biotech Investment Rating

  • Master Rating:
  • Medicamen Biotech has an operating revenue of Rs. 121.00 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of 16% is great, ROE of 10% is good. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 7% and 27% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 13% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 56 which is a POOR score indicating inconsistency in earnings, a RS Rating of 82 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 124 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Medicamen Biotech Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 332333332820
Operating Expenses Qtr Cr 271826262115
Operating Profit Qtr Cr 656665
Depreciation Qtr Cr 222110
Interest Qtr Cr 110000
Tax Qtr Cr 101111
Net Profit Qtr Cr 434444

Medicamen Biotech Technicals

EMA & SMA

Current Price
983.4
-5.7 (-0.58%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 1038.4
  • 50 Day
  • 954.08
  • 100 Day
  • 868.13
  • 200 Day
  • 779.54
  • 20 Day
  • 1073.56
  • 50 Day
  • 930.13
  • 100 Day
  • 792.98
  • 200 Day
  • 778.84

Medicamen Biotech Resistance and Support

PIVOT
₹993.47
Resistance
First Resistance 1009.04
Second Resistance 1028.97
Third Resistance 1044.54
RSI 44.05
MFI 44.52
MACD Single Line 41.38
MACD 15.36
Support
First Resistance 973.54
Second Resistance 957.97
Third Resistance 938.04

Medicamen Biotech Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 22,179 993,619 44.8
Week 35,567 1,455,062 40.91
1 Month 35,674 1,887,162 52.9
6 Month 32,952 1,717,780 52.13

Medicamen Biotech Result Highlights

Medicamen Biotech Synopsis

NSE-Medical-Generic Drugs

Medicamen Biotec is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 110.15 Cr. and Equity Capital is Rs. 12.22 Cr. for the Year ended 31/03/2021. Medicamen Biotech Ltd. is a Public Limited Listed company incorporated on 22/12/1993 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1993PLC056594 and registration number is 056594.
Market Cap 1,244
Sales 121
Shares in Float 0.72
No of funds 2
Yield 0.1
Book Value 8.12
U/D Vol ratio 1.8
LTDebt / Equity 3
Alpha 0.29
Beta 0.82

Medicamen Biotech

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 43.21%43.6%43.6%
Mutual Funds
Foreign Portfolio Investors 0.42%0.35%0.4%
Individual Investors 35.26%35.02%34.31%
Others 21.11%21.03%21.69%

Medicamen Biotech Management

Name Designation
Mr. Rahul Bishnoi Chairman
Dr. Vimal Kumar Shrawat Non Executive Director
Mr. Sanjay Bansal Non Executive Director
Mr. Suresh Kumar Singh Non Executive Director
Mr. Ashwani Kumar Sharma Non Executive Director
Mr. Harish Pande Independent Director
Mr. Arun Kumar Independent Director
Ms. Sumita Dwivedi Independent Director
Ms. Sangeeta Bishnoi Independent Director
Dr. Ravi Kumar Bansal Independent Director

Medicamen Biotech Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Medicamen Biotech Corporate Action

Date Purpose Remarks
2022-08-10 Quarterly Results
2022-08-01 Preferential issue of shares
2022-05-25 Audited Results & Final Dividend
2022-02-08 Quarterly Results
2021-11-03 Quarterly Results

Medicamen Biotech MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Medicamen Biotech FAQs

What is Share Price of Medicamen Biotech ?

Medicamen Biotech share price is ₹983 As on 30 September, 2022 | 02:42

What is the Market Cap of Medicamen Biotech ?

The Market Cap of Medicamen Biotech is ₹1244.1 Cr As on 30 September, 2022 | 02:42

What is the P/E ratio of Medicamen Biotech ?

The P/E ratio of Medicamen Biotech is 83.8 As on 30 September, 2022 | 02:42

What is the PB ratio of Medicamen Biotech ?

The PB ratio of Medicamen Biotech is 8.2 As on 30 September, 2022 | 02:42

Q1FY23